Point-of-Care (POC) Testing Devices Market, by Product Type (Glucose Testing Devices, Infectious Disease Testing Devices, Coagulation Testing Devices, Fertility and Pregnancy Testing Devices, Urine Analysis Testing Devices, Cardiac Markers Testing Devices, Hematology Testing Devices, Cholesterol Testing Devices, Drug Of Abuse Testing Devices, Others), by End-Users (Hospitals, Clinics, Diagnostic Laboratories, Research Institutes, Others) and, by Distribution Channel (Online Stores, Retail Stores, Direct Selling): Opportunity Analysis and Industry Forecast, 2023-2032

The report on Point-of-care (poc) testing devices market provides related insights, information, and recommendation to market stakeholder to achieve their priorities and enable the growth by taking the right decisions. The research covers Point-of-care (poc) testing devices market across multiple countries and companies. The report is based on rigorous research methodology, which includes extensive desk research using quantitative/statistical methods, qualitative analysis, and primary interviews. This report examines the market scope, revenue size, and growth of the global Point-of-care (poc) testing devices market in value terms, and also tracks the key trends at regional level. Moreover, it includes qualitative analysis on different parameters such as impact on market size, regulatory framework, economic impact, key player strategies, and opportunity window. The company profile section of the report covers company overview, key executives, company snapshot, operating business segments, product/service portfolio, R&D expenditure, business performance, and key strategic moves & developments. The global Point-of-care (poc) testing devices market is segmented depending on by product type, by end-users, by distribution channel.

Key Companies identified in the report are Roche Holding AG, Abbott Laboratories Inc, Siemens Healthineers AG, Johnson and Johnson Inc, Orscheln Products LLC, BD (Becton Dickinson), OraSure Technologies Inc, Trinity Biotech Plc, Chembio Diagnostics Inc, Alere Inc

Deliverables:

• Market size value forecast by country

• Regional level market trends and dynamics

• Porter’s Five Forces Model and PESTLE Analysis

• Company profile, competition landscape inclusive of competition dashboard, heatmap analysis, and product/service offerings

• Key developmental strategies and M&A activities

• Country Wise market size and forecast for each segment

• Market Share of Leading Players worldwide

Market Taxonomy

This Point-of-care (poc) testing devices market is segmented on the basis of by product type, by end-users, by distribution channel. On the basis of region, the global Point-of-care (poc) testing devices market is analyzed across North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.

  Point-of-Care Report Highlights

Aspects	Details
By Product Type	Glucose Testing Devices Infectious Disease Testing Devices Coagulation Testing Devices Fertility and Pregnancy Testing Devices Urine Analysis Testing Devices Cardiac Markers Testing Devices Hematology Testing Devices Cholesterol Testing Devices Drug Of Abuse Testing Devices Others
By End-Users	Hospitals Clinics Diagnostic Laboratories Research Institutes Others
By Distribution Channel	Online Stores Retail Stores Direct Selling
By Region	North America  (U.S., Canada, Mexico) Europe  (France, Germany, Italy, Spain, UK, Russia, Rest of Europe) Asia-Pacific  (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Rest of Asia-Pacific) LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Argentina, Rest of LAMEA)
Key Market Players	Orscheln Products LLC, Alere Inc, Roche Holding AG, BD (Becton Dickinson), Trinity Biotech Plc, Johnson and Johnson Inc, Chembio Diagnostics Inc, Abbott Laboratories Inc, OraSure Technologies Inc, Siemens Healthineers AG

^*Terms and Conditions Apply